Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University's Institute for Psychedelic Research
May 09, 2024 08:00 ET | Optimi Health Corp.
Export Permit granted: Optimi's Shipment of MDMA active pharmaceutical ingredient (API) to Israel marks the Company’s first international export
Isracann BioSciences Logo RGB@4x-100 LG.jpg
Isracann Prepares for Israel’s New Cannabis Export Permit Process and Announces New COO
June 04, 2020 00:05 ET | Isracann Biosciences Inc.
VANCOUVER, British Columbia, June 04, 2020 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on...